Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KUALA: a machine learning-driven framework for kinase inhibitors repositioning. | Sci Rep | 2022 | 36284125 | PubTator, text mining | PubMed |
| The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications. | Front Oncol | 2022 | 36276147 | PubTator, text mining | PubMed |
| Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia. | Front Oncol | 2022 | 36276124 | PubTator, text mining | PubMed |
| IQGAP3 in clear cell renal cell carcinoma contributes to drug resistance and genome stability. | PeerJ | 2022 | 36275458 | PubTator, text mining | PubMed |
| Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement. | Mater Today Bio | 2022 | 36267139 | PubTator, text mining | PubMed |
| Discoidin domain receptor 1 regulates ErbB2/ErbB3 signaling in mammary epithelial cells. | FEBS Lett | 2022 | 36266942 | PubTator, text mining | PubMed |
| DDR1 activation in macrophage promotes IPF by regulating NLRP3 inflammasome and macrophage reaction. | Int Immunopharmacol | 2022 | 36257259 | PubTator, text mining | PubMed |
| Editorial: Collagen IV nephropathies: Alport syndrome and beyond. | Front Med (Lausanne) | 2022 | 36250080 | PubTator, text mining | PubMed |
| Genetic and pharmacological tools to study the role of discoidin domain receptors in kidney disease. | Front Pharmacol | 2022 | 36249782 | PubTator, text mining | PubMed |
| Treatment of primary tracheal schwannoma with endoscopic resection: A case report. | World J Clin Cases | 2022 | 36246804 | PubTator, text mining | PubMed |
| The two facets of receptor tyrosine kinase in cardiovascular calcification-can tyrosine kinase inhibitors benefit cardiovascular system? | Front Cardiovasc Med | 2022 | 36237897 | PubTator, text mining | PubMed |
| Role of myeloid-derived suppressor cells in the formation of pre-metastatic niche. | Front Oncol | 2022 | 36237333 | PubTator, text mining | PubMed |
| Collagen Type XI Inhibits Lung Cancer-Associated Fibroblast Functions and Restrains the Integrin Binding Site Availability on Collagen Type I Matrix. | Int J Mol Sci | 2022 | 36233024 | PubTator, text mining | PubMed |
| Multiplexed In Situ Spatial Protein Profiling in the Pursuit of Precision Immuno-Oncology for Patients with Breast Cancer. | Cancers (Basel) | 2022 | 36230808 | PubTator, text mining | PubMed |
| Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer. | Cancers (Basel) | 2022 | 36230542 | PubTator, text mining | PubMed |
| Targeting TM4SF1 exhibits therapeutic potential via inhibition of cancer stem cells. | Signal Transduct Target Ther | 2022 | 36229443 | PubTator, text mining | PubMed |
| A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancer. | Am J Cancer Res | 2022 | 36225647 | PubTator, text mining | PubMed |
| Target-specific compound selectivity for multi-target drug discovery and repurposing. | Front Pharmacol | 2022 | 36225560 | PubTator, text mining | PubMed |
| Molecular targeted therapy for anticancer treatment. | Exp Mol Med | 2022 | 36224343 | PubTator, text mining | PubMed |
| A MYC-ZNF148-ID1/3 regulatory axis modulating cancer stem cell traits in aggressive breast cancer. | Oncogenesis | 2022 | 36207293 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=29